Asgard Therapeutics
Asgard Therapeutics is a cancer Immunotherapy founded in 2018.
2
Funding Rounds
$6.9m
Money raised
Funding series
Funding Series Analysis
The company Asgard Therapeutics has raised a total of $6.9m in funding over 2 rounds.
Key Insights:
- Asgard Therapeutics November 2021 Seed Funding Round: $6.9m
Asgard Therapeutics November 2021 Seed Funding Round
$6.9m
Industries
Asgard Therapeutics is active in the following industries: